Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 10,000 shares at $61.31 ($608K) on 2019-03-21, disclosed to the SEC on 2019-03-25.
Open-market sale of $608k RGNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.64 | 8,300 | $503K | 82.8% |
| 2 | $61.31 | 1,700 | $104K | 17.2% |
| Total | $60.75 avg | 10,000 | $608K | 100% |
| Filing → |
| RGNX | SELL | 2022-08-03 | $75K | — | Filing → |
| RGNX | SELL | 2022-07-15 | $274K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |